Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Temporary Equity and Common Stockholders' Equity (Deficit) (Unaudited)

v3.21.2
Consolidated Statements of Temporary Equity and Common Stockholders' Equity (Deficit) (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Series A Preferred Stock [Member]
Preferred Stock [Member]
Series B Preferred Stock [Member]
Preferred Stock [Member]
Series C Preferred Stock [Member]
Preferred Stock [Member]
Temporary Equity [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Beginning balance, value at Dec. 31, 2019 $ 12,356 $ 18,045 $ 30,401 $ 1,047 $ (29,304) $ (28,257)
Beginning Balance, shares at Dec. 31, 2019 4,612 3,735   2,456        
Issuance of shares for services $ 30 30 40 40
Issuance of shares for services, shares   5     20        
Exercise of stock options 85 85
Exercise of stock options, shares         47        
Related party note payable exchange for stock option exercise 26 26
Related party note payable exchange for stock option exercise, shares         12        
Executives deferred compensation settled with restricted tock 86 86
Executives deferred compensation settled with restricted tock,shares         43        
Issuance of Series B Convertible Preferred shares, net of issuance costs of $41 $ 1,250 1,250
Issuance of Series B Convertible Preferred shares, net of issuance costs of $41, shares   236              
Exchange of Series B Preferred Stock for 2020 Convertible Notes $ (2,593) (2,593)
Exchange of Series B Preferred Stock for 2020 Convertible Notes, shares   (472)              
Stock-based compensation 170 170
Net loss (6,296) (6,296)
Ending balance, value at Sep. 30, 2020 $ 12,356 $ 16,732 29,088 1,454 (35,600) (34,146)
Ending balance, shares at Sep. 30, 2020 4,612 3,504   2,578        
Beginning balance, value at Dec. 31, 2019 $ 12,356 $ 18,045 30,401 1,047 (29,304) (28,257)
Beginning Balance, shares at Dec. 31, 2019 4,612 3,735   2,456        
Ending balance, value at Dec. 31, 2020 $ 12,356 $ 16,651 29,007 1,514 (37,954) (36,440)
Ending balance, shares at Dec. 31, 2020 4,612 3,489   2,594        
Beginning balance, value at Jun. 30, 2020 $ 12,356 $ 16,756 29,112 1,173 (32,610) (31,437)
Beginning Balance, shares at Jun. 30, 2020 4,612 3,508   2,472        
Issuance of shares for services 34 34
Issuance of shares for services, shares         16        
Exercise of stock options 62 62
Exercise of stock options, shares         35        
Related party note payable exchange for stock option exercise 26 26
Related party note payable exchange for stock option exercise, shares         12        
Executives deferred compensation settled with restricted tock 86 86
Executives deferred compensation settled with restricted tock,shares         43        
Exchange of Series B Preferred Stock for 2020 Convertible Notes $ (24) (24)
Exchange of Series B Preferred Stock for 2020 Convertible Notes, shares   (4)              
Stock-based compensation 73 73
Net loss (2,990) (2,990)
Ending balance, value at Sep. 30, 2020 $ 12,356 $ 16,732 29,088 1,454 (35,600) (34,146)
Ending balance, shares at Sep. 30, 2020 4,612 3,504   2,578        
Beginning balance, value at Dec. 31, 2020 $ 12,356 $ 16,651 29,007 1,514 (37,954) (36,440)
Beginning Balance, shares at Dec. 31, 2020 4,612 3,489   2,594        
Exercise of stock options 4 4
Issuance of Series C Convertible Preferred shares, net of issuance costs of $214 $ 1,786 1,786
Issuance of Series C Convertible Preferred shares, net of issuance costs of $214, shares     567            
Issuance of Common Stock for acquisition consideration $ 2 59,918 59,920
Issuance of Common Stock for acquisition consideration, shares         11,007        
Issuance of incremental shares to StemoniX shareholders upon Merger
Issuance of incremental shares to StemoniX shareholders upon Merger, shares         805        
Conversion of Preferred Stock to Common Stock upon Merger $ (12,356) $ (16,651) $ (1,786) (30,793) $ 1 30,792 30,793
Conversion of preferred stock to common stock upon merger, shares (4,612) (3,489) (567)   11,197        
Conversion of 2020 Convertible Notes to Common Stock upon Merger 16,190 16,190
Conversion of 2020 convertible notes to common sock upon merger, shares         3,339        
Preferred stock warrant settled for Common Stock upon Merger
Preferred stock warrant settled for Common Stock upon Merger , shares         43        
Warrant liability reclassified to equity upon Merger 421 421
Stock-based compensation 1,025 1,025
Foreign currency translation adjustment 16 16
Net loss (16,013) (16,013)
Ending balance, value at Sep. 30, 2021 $ 3 109,864 (53,967) 16 55,916
Ending balance, shares at Sep. 30, 2021   28,985        
Beginning balance, value at Jun. 30, 2021 $ 3 $ 109,567 $ (49,506) $ (1) $ 60,063
Beginning Balance, shares at Jun. 30, 2021   28,985        
Exercise of stock options, shares
Issuance of Series C Convertible Preferred shares, net of issuance costs of $214, shares      
Conversion of preferred stock to common stock upon merger, shares      
Exchange of Series B Preferred Stock for 2020 Convertible Notes
Exchange of Series B Preferred Stock for 2020 Convertible Notes, shares
Stock-based compensation $ 297 $ 297
Foreign currency translation adjustment 17 17
Net loss (4,461) (4,461)
Ending balance, value at Sep. 30, 2021 $ 3 $ 109,864 $ (53,967) $ 16 $ 55,916
Ending balance, shares at Sep. 30, 2021   28,985